Restricted accessResearch articleFirst published online 2026-4
Association of the endothelial activation and stress Index (EASIX) with cognitive function in United States older adults: Findings from NHANES 2011–2014
Cognitive decline poses a significant public health challenge in aging populations. Endothelial dysfunction is increasingly recognized as a key mechanism linking vascular pathology to cognitive impairment. The Endothelial Activation and Stress Index (EASIX), derived from routine laboratory measures, has been associated with vascular outcomes, but its relationship with cognitive function in the general aging population remains unexplored.
Objective
This study aimed to investigate the association between EASIX and cognitive performance among community-dwelling older adults.
Methods
We analyzed data from 2143 participants aged ≥60 from NHANES 2011–2014. EASIX was calculated as (creatinine × lactate dehydrogenase) / platelet count. Cognitive function was assessed using the Consortium to Establish a Registry for Alzheimer's Disease Word Learning (CERAD-WL) and Delayed Recall tests, Animal Fluency Test (AFT), and Digit Symbol Substitution Test (DSST). Survey-weighted linear and logistic regression models were employed to examine associations between EASIX and cognitive outcomes, adjusting for multiple covariates.
Results
Each unit increase in EASIX was significantly associated with lower scores on the DSST (β = –1.94, 95% CI: −2.79 to −1.10), AFT (β = –0.77, 95% CI: −1.04 to −0.50), and CERAD-WL (β = –0.53, 95% CI: −0.94 to −0.13). Higher EASIX was also associated with increased odds of cognitive dysfunction on AFT (OR = 1.22, 95% CI: 1.05–1.42) and DSST (OR = 1.66, 95% CI: 1.09–2.52). Associations remained robust in sensitivity analyses.
Conclusions
EASIX is independently associated with domain-specific cognitive decline in older adults, supporting its potential utility as an accessible biomarker of cognitive aging.
BeardJROfficerAde CarvalhoIA, et al.The world report on ageing and health: a policy framework for healthy ageing. Lancet2016; 387: 2145–2154.
2.
LivingstonGHuntleyJSommerladA, et al.Dementia prevention, intervention, and care: 2020 report of the lancet commission. Lancet2020; 396: 413–446.
3.
KnopmanDSGottesmanRFSharrettAR, et al.Midlife vascular risk factors and midlife cognitive status in relation to prevalence of mild cognitive impairment and dementia in later life: the atherosclerosis risk in communities study. Alzheimers Dement2018; 14: 1406–1415.
4.
FangY-CHsiehY-CHuC-J, et al.Endothelial dysfunction in neurodegenerative diseases. Int J Mol Sci2023; 24: 2909.
5.
GoncharovNVPopovaPIKudryavtsevIV, et al.Immunological profile and markers of endothelial dysfunction in elderly patients with cognitive impairments. Int J Mol Sci2024; 25: 1888.
6.
HosokiSHansraGKJayasenaT, et al.Molecular biomarkers for vascular cognitive impairment and dementia. Nat Rev Neurol2023; 19: 737–753.
7.
ShouvalRFeinJAShouvalA, et al.External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation. Blood Adv2019; 3: 1881–1890.
8.
LuftTBennerATerzerT, et al.EASIX And mortality after allogeneic stem cell transplantation. Bone Marrow Transplant2019; 55: 553–561.
9.
HuangYLiZWangJ, et al.Endothelial activation and stress index is a reliable predictor for the prevalence and mortality outcomes of stroke. Sci Rep2025; 15: 23285.
10.
ZhaoEChenYXieH, et al.Association between the endothelial activation and stress Index (EASIX) and all-cause and cardiovascular mortality in patients with diabetes and prediabetes. Eur J Med Res2025; 30: 730.
11.
DongGWuTGuX, et al.Endothelial activation and stress index predicts all-cause and cardiovascular mortality in hypertensive individuals: a nationwide study. J Clin Hypertens (Greenwich)2025; 27: e70057.
12.
WangRJiangYHeM, et al.EASIX Is an effective marker in predicting mortality of traumatic brain injury patients. Eur J Med Res2024; 29: 300.
13.
BăetuAEMireaLECobilinschiC, et al.Platelet contribution and endothelial activation and stress index-potential mortality predictors in traumatic brain injury. Int J Mol Sci2024; 25: 7763.
14.
BaileyRLJunSMurphyL, et al.High folic acid or folate combined with low vitamin B-12 status: potential but inconsistent association with cognitive function in a nationally representative cross-sectional sample of us older adults participating in the NHANES. Am J Clin Nutr2020; 112: 1547–1557.
15.
LevisBBenedettiAThombsBD. Accuracy of patient health questionnaire-9 (phq-9) for screening to detect major depression: individual participant data meta-analysis. Br Med J2019; 365: l1476.
16.
AnandSSFriedrichMGLeeDS, et al.Evaluation of adiposity and cognitive function in adults. JAMA Netw Open2022; 5: e2146324.
17.
PunthakeeZMillerMELaunerLJ, et al.Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes. Diabetes Care2012; 35: 787–793.
18.
ElfassyTAielloAESchneidermanN, et al.Relation of diabetes to cognitive function in Hispanics/Latinos of diverse backgrounds in the United States. J Aging Health2018; 31: 1155–1171.
19.
GottesmanRFSchneiderALCAlbertM, et al.Midlife hypertension and 20-year cognitive change. JAMA Neurol2014; 71: 1218–1227.
20.
RestifoDZhaoCKamelH, et al.Impact of cigarette smoking and its interaction with hypertension and diabetes on cognitive function in older Americans. J Alzheimers Dis2022; 90: 1705–1712.
21.
DotsonVMZondermanABKrautMA, et al.Temporal relationships between depressive symptoms and white matter hyperintensities in older men and women. Int J Geriatr Psychiatry2012; 28: 66–74.
22.
YangHJSongJMLeeS, et al.The different associations of white matter hyperintensities with severity of dementia and cognitive impairment according to the distance from the lateral ventricular surface in patients with Alzheimer’s disease. Psychiatry Investig2024; 21: 850–859.
23.
FengMZhangYLiuY, et al.White matter structural network analysis to differentiate Alzheimer’s disease and subcortical ischemic vascular dementia. Front Aging Neurosci2021; 13: 650377.
24.
ZimmermannGJolyLSchoepferP, et al.Interactions between brain 18F-FDG PET metabolism and hemodynamic parameters at different ages of life: results from a prospective cross-sectional study. Front Aging Neurosci2022; 14: 908063.
25.
BubbEJMetzler-BaddeleyCAggletonJP. The cingulum bundle: anatomy, function, and dysfunction. Neurosci Biobehav Rev2018; 92: 104–127.
26.
WangH-KSuY-THoY-C, et al.HDAC1 Is involved in neuroinflammation and blood-brain barrier damage in stroke pathogenesis. J Inflamm Res2023; 16: 4103–4116.
27.
LeonciniGViazziFParodiD, et al.Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension. Hypertension2003; 42: 14–18.
28.
ViggianoDWagnerCAMartinoG, et al.Mechanisms of cognitive dysfunction in CKD. Nat Rev Nephrol2020; 16: 452–469.
29.
LiRFengCLinK, et al.Associação da ativação endotelial e do Índice de estresse com risco de doença cardiovascular e mortalidade por todas as causas em pacientes com osteoartrite. Arq Bras de Cardiol2025; 122: e20250012.
30.
GardenerHWrightCBDongC, et al.Ideal cardiovascular health and cognitive aging in the northern Manhattan study. J Am Heart Assoc2016; 5: e002731.
31.
AndrabiSSParvezSTabassumH. Ischemic stroke and mitochondria: mechanisms and targets. Protoplasma2019; 257: 335–343.
32.
WangX-xWangFMaoG-h, et al.NADPH Is superior to NADH or edaravone in ameliorating metabolic disturbance and brain injury in ischemic stroke. Acta Pharmacol Sin2021; 43: 529–540.
33.
GalderisiSPerrottelliAGiulianiL, et al.Cognitive impairment after recovery from COVID-19: frequency, profile, and relationships with clinical and laboratory indices. Eur Neuropsychopharmacol2024; 79: 22–31.
34.
AnHShaoCHeY, et al.Calycosin inhibit panoptosis and alleviate brain damage: a bioinformatics and experimental verification approach. ACS Chem Neurosci2025; 16: 1550–1564.
35.
CheJSunYDengY, et al.Blood-brain barrier disruption: a culprit of cognitive decline?Fluids Barriers CNS2024; 21: 63.
36.
SeligerSLSiscovickDSStehman-BreenCO, et al.Moderate renal impairment and risk of dementia among older adults. J Am Soc Nephrol2004; 15: 1904–1911.
37.
BeckerBFJacobMLeipertS, et al.Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases. Br J Clin Pharmacol2015; 80: 389–402.
38.
LogsdonAFRheaEMReedM, et al.The neurovascular extracellular matrix in health and disease. Exp Biol Med (Maywood)2020; 246: 835–844.
39.
ReedMJDamodarasamyMBanksWA. The extracellular matrix of the blood–brain barrier: structural and functional roles in health, aging, and Alzheimer’s disease. Tissue Barriers2019; 7: 1651157.
40.
ZhangYLiuJWeiZ, et al.Elevated serum platelet count inhibits the effects of brain functional changes on cognitive function in patients with mild cognitive impairment: a resting-state functional magnetic resonance imaging study. Front Aging Neurosci2023; 15: 1088095.
41.
XuFHuJLiX, et al.Inhibition of platelet activation alleviates diabetes-associated cognitive dysfunction via attenuating blood-brain barrier injury. Brain Res Bull2025; 221: 111211.
42.
LeiterOWalkerTL. Platelets: the missing link between the blood and brain?Prog Neurobiol2019; 183: 101695.
43.
AlkhalifaAEAl-GhraiybahNFOdumJ, et al.Blood–brain barrier breakdown in Alzheimer’s disease: mechanisms and targeted strategies. Int J Mol Sci2023; 24: 16288.
44.
McFadyenJPeterK. Forget about thrombosis: platelets and Alzheimer’s disease, yet another sticky situation. Sci Signal2016; 9: fs9.
45.
KniewallnerKMFoidlBMHumpelC. Platelets isolated from an Alzheimer mouse damage healthy cortical vessels and cause inflammation in an organotypic ex vivo brain slice model. Sci Rep2018; 8: 15483.
